Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 34, Issue 4, 2013, Pages 312-319

  Ahn, Dongbin ^a   Sohn, Jin Ho ^a   Kim, Jae Hyug ^a   Shin, Chang Min ^a   Jeon, Jae Han ^b   Park, Ji Young ^b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SUBCLINICAL HYPOTHYROIDISM; THYROID CARCINOMA; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPOTHYROIDISM; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; THYROID FUNCTION TESTS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84879696806     PISSN: 01960709     EISSN: 1532818X     Source Type: Journal    
DOI: 10.1016/j.amjoto.2012.12.013     Document Type: Article

References (24)

1. A. Hercbergs, and J.T. Leith Spontaneous remission of metastatic lung cancer following myxedema coma - an apoptosis-related phenomenon? J Natl Cancer Inst 85 1993 1342 1343
2. A. Hercbergs The thyroid gland as an intrinsic biologic response-modifier in advanced neoplasia - a novel paradigm In Vivo 10 1996 245 247
3. C. Theodossiou, N. Skrepnik, and E.G. Robert Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice Cancer 86 1999 1596 1601
4. H.Y. Lin, M. Sun, and H.Y. Tang L-Thyroxine vs. 3,5,3′-triiodo-L- thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase Am J Physiol Cell Physiol 296 2009 C980 C991
5. S.Y. Cheng, J.L. Leonard, and P.J. Davis Molecular aspects of thyroid hormone actions Endocr Rev 31 2010 139 170
6. M. Yalcin, E. Dyskin, and L. Lansing Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid J Clin Endocrinol Metab 95 2010 1972 1980
7. H.Y. Lin, H.Y. Tang, and A. Shih Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic Steroids 72 2007 180 187
8. S.S. Kim, B.J. Lee, and J.C. Lee Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience Endocrine 39 2011 259 265
9. A.H. Hercbergs, O. Ashur-Fabian, and D. Garfield Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology Curr Opin Endocrinol Diabetes Obes 17 2010 432 436
10. D. Ahn, S.J. Heo, and J.H. Park Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer Acta Oncol 50 2011 1228 1234
11. S.D. Larson, L.N. Jackson, and T.S. Riall Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway J Am Coll Surg 204 2007 764 773 [discussion 73-5]
12. D. Repplinger, A. Bargren, and Y.W. Zhang Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 150 2008 49 52
13. E.Y. Kim, W.G. Kim, and W.B. Kim Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma Clin Endocrinol (Oxf) 71 2009 581 586
14. N.F. Col, M.I. Surks, and G.H. Daniels Subclinical thyroid disease: clinical applications JAMA 291 2004 239 243
15. M.I. Surks, E. Ortiz, and G.H. Daniels Subclinical thyroid disease: scientific review and guidelines for diagnosis and management JAMA 291 2004 228 238
16. G.J. Canaris, N.R. Manowitz, and G. Mayor The Colorado thyroid disease prevalence study Arch Intern Med 160 2000 526 534
17. E. Fiore, T. Rago, and F. Latrofa Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine Endocr Relat Cancer 18 2011 429 437
18. E. Fiore, T. Rago, and M.A. Provenzale Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role Endocr Relat Cancer 16 2009 1251 1260
19. D.A. Hoffman, W.M. McConahey, and L.A. Brinton Breast cancer in hypothyroid women using thyroid supplements JAMA 251 1984 616 619
20. M. Schmidinger, U.M. Vogl, and M. Bojic Hypothyroidism in patients with renal cell carcinoma: blessing or curse? Cancer 117 2011 534 544
21. M. Cristofanilli, Y. Yamamura, and S.W. Kau Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma Cancer 103 2005 1122 1128
22. N. Sato, M. Oyamatsu, and Y. Koyama Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 69 1998 151 155
23. D. Ahn, S.J. Lee, and S.K. Park Is comprehensive neck dissection a sole choice for the treatment of recurrent papillary thyroid carcinoma in the lateral neck? Korean J Otorhinolaryngol-Head Neck Surg 54 2011 62 68
24. M. Gerschpacher, C. Gobl, and C. Anderwald Thyrotropin serum concentrations in patients with papillary thyroid microcancers Thyroid 20 2010 389 392